UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Population pharmacokinetics and exposure‐response analysis of a single dose of sotrovimab in the early treatment of patients with mild to moderate COVID‐19

CPT: pharmacometrics and systems pharmacology, 2023-06, Vol.12 (6), p.853-864

2023

Volltextzugriff (PDF)

Assessment of symptoms in COMET-ICE, a phase 2/3 study of sotrovimab for early treatment of non-hospitalized patients with COVID-19

Journal of patient-reported outcomes, 2023-09, Vol.7 (1), p.92-92, Article 92

2023

Volltextzugriff (PDF)

Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab

The New England journal of medicine, 2021-11, Vol.385 (21), p.1941-1950

2021

Volltextzugriff (PDF)

Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2022-04, Vol.327 (13), p.1236

2022

Volltextzugriff (PDF)

Administration of BPX-501 Cells Following Αβ- T and B-Cell-Depleted HLA-Haploidentical HSCT in Children with Fanconi Anemia

Blood, 2018-11, Vol.132 (Supplement 1), p.4654-4654

2018

Volltextzugriff (PDF)

Characterization of Allogeneic T Cells Expressing Inducible Caspase-9 Following Adoptive Transfer in Children Receiving an HLA-Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Myeloid Malignancies

Blood, 2018-11, Vol.132 (Supplement 1), p.4534-4534

2018

Volltextzugriff (PDF)

Administration of Rimiducid Following Haploidentical BPX-501 Cells in Children with Malignant or Non-Malignant Disorders Who Develop Graft-Versus-Host-Disease (GvHD)

Blood, 2018-11, Vol.132 (Supplement 1), p.2207-2207

2018

Volltextzugriff (PDF)

304. Viral resistance analysis in the COMET-PEAK study: sotrovimab treatment in participants with mild-to-moderate COVID-19

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

Resistance analysis following sotrovimab treatment in participants with COVID-19 during the phase III COMET-ICE study

Future virology, 2023-10, Vol.18 (15), p.975-990

2023

Volltextzugriff (PDF)

Resistance analysis in the phase III COMET-TAIL study: treatment of COVID-19 with intramuscular or intravenous sotrovimab

Future virology, 2024-03, Vol.19 (5), p.185-198

2024

Volltextzugriff (PDF)

1150. Resistance Analysis in the COMET-TAIL Study: Participants with Mild-to-Moderate COVID-19 Treated with Intramuscular or Intravenous Sotrovimab

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

Safety, Virology, Pharmacokinetics, and Clinical Experience of High-Dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-Label Clinical Trial

Open forum infectious diseases, 2023-07, Vol.10 (7), p.ofad344-ofad344

2023

Volltextzugriff (PDF)

1154. Safety, Tolerability, and Viral Pharmacodynamics of the IgG Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection for the Treatment of Early Mild-to-Moderate COVID-19

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

2022

Volltextzugriff (PDF)

502. Early COVID-19 Treatment with SARS-CoV-2 Neutralizing Antibody Sotrovimab

Open forum infectious diseases, 2021-12, Vol.8 (Supplement_1), p.S353-S354

2021

Volltextzugriff (PDF)

Antibody therapy reverses biological signatures of COVID-19 progression

Cell reports. Medicine, 2022-08, Vol.3 (8), p.100721-100721, Article 100721

2022

Volltextzugriff (PDF)

Si(100) Etching in Aqueous Fluoride Solutions: Parallel Etching Reactions Lead to pH-Dependent Nanohillock Formation or Atomically Flat Surfaces

Journal of physical chemistry. C, 2012-10, Vol.116 (40), p.21499-21507

2012

Volltextzugriff (PDF)

Aqueous Etching Produces Si(100) Surfaces of Near-Atomic Flatness: Strain Minimization Does Not Predict Surface Morphology

Journal of physical chemistry. C, 2010-01, Vol.114 (1), p.423-428

2010

Volltextzugriff (PDF)

Heterozygous variants in MYH10 associated with neurodevelopmental disorders and congenital anomalies with evidence for primary cilia-dependent defects in Hedgehog signaling

Genetics in medicine, 2022-10, Vol.24 (10), p.2065-2078

2022

Volltextzugriff (PDF)

Self-Propagating Reaction Produces Near-Ideal Functionalization of Si(100) and Flat Surfaces

Journal of physical chemistry. C, 2012-09, Vol.116 (35), p.18920-18929

2012

Volltextzugriff (PDF)

Kinetic Monte Carlo simulations of anisotropic Si(100) etching:Modeling the chemical origins of characteristic etch morphologies

The Journal of chemical physics, 2010-07, Vol.133 (4), p.044710-044710-13

2010

Volltextzugriff (PDF)

Extracting maximum information from polarized surface vibrational spectra: Application to etched, H-terminated Si(110) surfaces

The Journal of chemical physics, 2008-04, Vol.128 (14), p.144711-144711-9

2008

Volltextzugriff (PDF)

The same etchant produces both near-atomically flat and microfaceted Si(100) surfaces: The effects of gas evolution on etch morphology

Journal of applied physics, 2010-05, Vol.107 (10), p.103520-103520-11

2010

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(15)
Life Sciences & Biomedicine
(9)
Covid-19
(6)
Physical Sciences
(6)
Chemistry
(5)
Chemistry, Physical
(5)
Humans
(5)
Physics
(5)
Sars-Cov-2
(5)
Coronaviruses
(4)
Monoclonal Antibodies
(4)
Clinical Trials
(3)
Materials Science
(3)
Materials Science, Multidisciplinary
(3)
Monoclonal Antibody
(3)
Nanoscience & Nanotechnology
(3)
Patients
(3)
Risk Factors
(3)
Science & Technology - Other Topics
(3)
Sotrovimab
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Population pharmacokinetics and exposure‐response analysis of a single dose of sotrovimab in the early treatment of patients with mild to moderate COVID‐19

Assessment of symptoms in COMET-ICE, a phase 2/3 study of sotrovimab for early treatment of non-hospitalized patients with COVID-19

Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab

Effect of Sotrovimab on Hospitalization or Death Among High-risk Patients With Mild to Moderate COVID-19: A Randomized Clinical Trial

Administration of BPX-501 Cells Following Αβ- T and B-Cell-Depleted HLA-Haploidentical HSCT in Children with Fanconi Anemia

Characterization of Allogeneic T Cells Expressing Inducible Caspase-9 Following Adoptive Transfer in Children Receiving an HLA-Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Myeloid Malignancies

Administration of Rimiducid Following Haploidentical BPX-501 Cells in Children with Malignant or Non-Malignant Disorders Who Develop Graft-Versus-Host-Disease (GvHD)

304. Viral resistance analysis in the COMET-PEAK study: sotrovimab treatment in participants with mild-to-moderate COVID-19

Resistance analysis following sotrovimab treatment in participants with COVID-19 during the phase III COMET-ICE study

Resistance analysis in the phase III COMET-TAIL study: treatment of COVID-19 with intramuscular or intravenous sotrovimab

1150. Resistance Analysis in the COMET-TAIL Study: Participants with Mild-to-Moderate COVID-19 Treated with Intramuscular or Intravenous Sotrovimab

Safety, Virology, Pharmacokinetics, and Clinical Experience of High-Dose Intravenous Sotrovimab for the Treatment of Mild to Moderate COVID-19: An Open-Label Clinical Trial

1154. Safety, Tolerability, and Viral Pharmacodynamics of the IgG Monoclonal Antibody Sotrovimab Administered via Intramuscular Injection for the Treatment of Early Mild-to-Moderate COVID-19

502. Early COVID-19 Treatment with SARS-CoV-2 Neutralizing Antibody Sotrovimab

Antibody therapy reverses biological signatures of COVID-19 progression

Si(100) Etching in Aqueous Fluoride Solutions: Parallel Etching Reactions Lead to pH-Dependent Nanohillock Formation or Atomically Flat Surfaces

Aqueous Etching Produces Si(100) Surfaces of Near-Atomic Flatness: Strain Minimization Does Not Predict Surface Morphology

Heterozygous variants in MYH10 associated with neurodevelopmental disorders and congenital anomalies with evidence for primary cilia-dependent defects in Hedgehog signaling

Self-Propagating Reaction Produces Near-Ideal Functionalization of Si(100) and Flat Surfaces

Kinetic Monte Carlo simulations of anisotropic Si(100) etching:Modeling the chemical origins of characteristic etch morphologies

Extracting maximum information from polarized surface vibrational spectra: Application to etched, H-terminated Si(110) surfaces

The same etchant produces both near-atomically flat and microfaceted Si(100) surfaces: The effects of gas evolution on etch morphology

Suchergebnisse filtern